Effect of the medical walking and leucine enriched amino acid containing food for non-alcoholic fatty liver disease : Randomized controled trial

Effect of the medical walking and leucine enriched amino acid containing food for non-alcoholic fatty liver disease : Randomized controled trial - Effect of the medical walking and leucine enriched amino acid containing food for NAFLD : Randomized controled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019131

Enrollment

Registered

2015-09-27

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

medical walking (3 months,8,000 steps / day) medical walking (3 months,8,000 steps / day)and leucine enriched amino acid containing food (3 months, 1 pack / day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)20 years old or older 2)The patients who had a diagnosis of NAFLD or NASH clinically or histologically 3)The ALT within four weeks is 40 IU/l or more 4)Enough informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1)Participant of other clinical trials 2)The patients whom doctors judged to be inadequate as subjects 3)The patients with allergy to apple

Design outcomes

Primary

Measure	Time frame
The change of ALT before the treatment and 12 weeks later	—

Countries

Japan

Contacts

Public ContactNoriko Ozawa

Takasaki General Medical Center, National Hospital Organization Clinical Research Department

tcr-jimu1@takasaki-hosp.jp+81273225901

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026